We regard aging as one of the highest risk factors for the onset of various diseases and aims to develop treatments for those diseases based on their biological and molecular mechanisms
reverSASP Therapeutics is a drug discovery biotech whose mission is to connect novel findings from aging biology with the development of innovative therapeutic drugs for patients
Our Strengths
First-in-class drug discovery with a unique drug discovery approach and platform technology in therapeutic areas with high unmet medical needs.
Multiple and original assets including gene therapy programs in the CNS field as the lead program.
Driving robust R&D efforts aimed at global clinical development by leveraging a highly experienced team across Japan, US, and Europe, along with expert advisory board.